Metoclopramide: Core Patient Variables
Metoclopramide: Core Patient Variables
•
Health status
–
Assess symptoms.
•
Life span and gender
–
Pregnancy Category B drug
•
Environment
–
Oral given in any environment; IV given in acute care
settings
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Metoclopramide: Nursing Diagnoses and
Outcomes
Metoclopramide: Nursing Diagnoses and
Outcomes
•
Risk for Self-Directed Violence secondary to adverse effects of
drug therapy
–
Desired outcome:
The patient will do no self-harm related
to depression from drug therapy.
•
Powerlessness related to extrapyramidal effects, Parkinson-like
symptoms, or tardive dyskinesia secondary to adverse effects of
drug therapy
–
Desired outcome:
The patient will make decisions
regarding own care, treatment, and future (when possible)
while on drug therapy.
•
Risk for Injury related to drowsiness, fatigue, insomnia, confusion,
and hallucination secondary to adverse effects of drug therapy
–
Desired outcome:
The patient will not suffer injury while on
drug therapy.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Metoclopramide: Planning and
Interventions
Metoclopramide: Planning and
Interventions
•
Maximizing therapeutic effects
–
Give oral doses 30 minutes before each meal.
–
Do not administer metoclopramide concurrently with
anticholinergic drugs.
•
Minimizing adverse effects
–
Monitor for evidence of depression.
–
Withhold the dose and notify the prescriber if
Parkinson-like symptoms occur.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Metoclopramide: Teaching, Assessment,
and Evaluation
Metoclopramide: Teaching, Assessment,
and Evaluation
•
Patient and family education
–
Tell patients to take metoclopramide 30 minutes
before meals.
–
Discuss side effects of drug.
–
Caution patients to avoid alcoholic beverages,
sedatives, and other CNS depressants.
•
Ongoing assessment and evaluation
–
With careful monitoring and follow-up assessments,
therapy can be considered successful if the patient’s
GI complaints diminish.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Question
Question
•
To promote optimal effectiveness of the drug,
metoclopramide should be given
–
A. 30 minutes before meals
–
B. At the start of the meal
–
C. 30 minutes after the meal
–
D. Three times a day without regard to meal times
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Answer
Answer
•
A. 30 minutes before meals
•
Rationale: Metoclopramide should be given 30
minutes before meals to achieve maximum
effectiveness.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Digestive Enzymes
Digestive Enzymes
•
Digestive enzymes are responsible for breaking down food
into forms that can be absorbed easily in the GI tract.
You've reached the end of your free preview.
Want to read all 69 pages?
- Fall '16
- Wolters Kluwer Health, Lippincott Williams & Wilkins
